Bio Protocol's banner
Bio Protocol's profile picture

Bio Protocol

@BioProtocol115,839 subscribers

Biotech's new financial layer.

Shorts

Say hello to PeptAI, a fleet of autonomous AI agents for peptide drug discovery, now live on Base Each agent targets a single receptor, runs the full nine-gate pipeline 24/7, and pays for its own wet-lab experiments via x402.

Say hello to PeptAI, a fleet of autonomous AI agents for peptide drug discovery, now live on Base Each agent targets a single receptor, runs the full nine-gate pipeline 24/7, and pays for its own wet-lab experiments via x402.

71,101 次观看

A new round of yapping XP is now live in the Bio App 🔮 Check your XP: This round covers August 25 to September 3. More XP distributions are coming and will occur before the next Ignition Sale. After this, BioXP will move to weekly distributions with plans to accelerate to every 3 to 7 days. What’s new in BioXP • Stronger detection of low quality or copy-paste posts • Fake or low quality replies will not earn XP • Weighting now favors BIO staking and ecosystem token staking Thank you for your patience as we refine this new system. High-velocity markets for autonomous discovery are kicking into overdrive. What’s next • Weekly automated XP distribution • Use BioXP and BIO to access the next Ignition Sale next week and future sales • The first BioAgent Aubrai is generating ideas for compounds, research and therapeutic methods. Validated data can be funded as IP Tokens via Ignition Sales • More BioAgent sales are coming, specialized across a range of scientific fields Yap. Stake. Accelerate. Onchain drug hunters lock in, it is science szn.

A new round of yapping XP is now live in the Bio App 🔮 Check your XP: This round covers August 25 to September 3. More XP distributions are coming and will occur before the next Ignition Sale. After this, BioXP will move to weekly distributions with plans to accelerate to every 3 to 7 days. What’s new in BioXP • Stronger detection of low quality or copy-paste posts • Fake or low quality replies will not earn XP • Weighting now favors BIO staking and ecosystem token staking Thank you for your patience as we refine this new system. High-velocity markets for autonomous discovery are kicking into overdrive. What’s next • Weekly automated XP distribution • Use BioXP and BIO to access the next Ignition Sale next week and future sales • The first BioAgent Aubrai is generating ideas for compounds, research and therapeutic methods. Validated data can be funded as IP Tokens via Ignition Sales • More BioAgent sales are coming, specialized across a range of scientific fields Yap. Stake. Accelerate. Onchain drug hunters lock in, it is science szn.

311,062 次观看

The next Ignition Sale is planned for next week. Another step in a long arc of experiments.

The next Ignition Sale is planned for next week. Another step in a long arc of experiments.

130,263 次观看

Bio Launchpad Season 2 Preview Season 2 of the Bio Launchpad is coming with key upgrades to BioXP, launch mechanics, liquidity & more. Highlights: • New Ignition Sales start as USDC/Asset pools, with BIO/Asset pools added for successful projects that show ongoing traction. • $BIO Staking incentives improved: staking BIO will earn you more BioXP + more rewards, with transparent staking formulas. • Aerodrome pool launcher integration: Eligible tokens launching on Bio will tradeable on Coinbase 🛡️ on day one. • Creator program: Yapping evolves → Apply to earn BioXP for your content. • Vesting for Ignition participants: proposed ~20% TGE, ~80% linear over ~30 days to share early market risk more fairly. • BNB bridge: Bridging BIO to BNB and creating the pathways for other ecosystem assets to be bridged. • x402 payments integration w/ BioAgents powering scientific agent commerce. + more TBA Season 1 generated a wealth of data and learnings across our first 5 BioAgent and IP Token launches, with 8k+ participants funding innovations in stem cell research, men’s health, psychedelic science & more. What's Next? Bio evolves from a high-touch launchpad into a permissionless factory for decentralized biotech. More BioAgents. More IP Tokens. New scientific domains. Open-source agent infra, permissionless onboarding and a cleaner route from curiosity to capital to lab. Keep staking. Keep stacking XP. S2 is coming.

Bio Launchpad Season 2 Preview Season 2 of the Bio Launchpad is coming with key upgrades to BioXP, launch mechanics, liquidity & more. Highlights: • New Ignition Sales start as USDC/Asset pools, with BIO/Asset pools added for successful projects that show ongoing traction. • $BIO Staking incentives improved: staking BIO will earn you more BioXP + more rewards, with transparent staking formulas. • Aerodrome pool launcher integration: Eligible tokens launching on Bio will tradeable on Coinbase 🛡️ on day one. • Creator program: Yapping evolves → Apply to earn BioXP for your content. • Vesting for Ignition participants: proposed ~20% TGE, ~80% linear over ~30 days to share early market risk more fairly. • BNB bridge: Bridging BIO to BNB and creating the pathways for other ecosystem assets to be bridged. • x402 payments integration w/ BioAgents powering scientific agent commerce. + more TBA Season 1 generated a wealth of data and learnings across our first 5 BioAgent and IP Token launches, with 8k+ participants funding innovations in stem cell research, men’s health, psychedelic science & more. What's Next? Bio evolves from a high-touch launchpad into a permissionless factory for decentralized biotech. More BioAgents. More IP Tokens. New scientific domains. Open-source agent infra, permissionless onboarding and a cleaner route from curiosity to capital to lab. Keep staking. Keep stacking XP. S2 is coming.

106,512 次观看

Longevity Hypothesis Challenge 👾 Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding. > Prompt Aubrai to generate & refine longevity hypotheses on X > Hypotheses get timestamped on Base using Molecule Proof of Invention (PoI) > Top ideas get published on ResearchHub and funded with 100K $RSC from the Bio treasury Already 700+ hypotheses have been generated by Aubrai. Now, it's time to start turning the best ideas into real-world experiments to support or refute them. Learn more:

Longevity Hypothesis Challenge 👾 Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding. > Prompt Aubrai to generate & refine longevity hypotheses on X > Hypotheses get timestamped on Base using Molecule Proof of Invention (PoI) > Top ideas get published on ResearchHub and funded with 100K $RSC from the Bio treasury Already 700+ hypotheses have been generated by Aubrai. Now, it's time to start turning the best ideas into real-world experiments to support or refute them. Learn more:

87,907 次观看

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.

BioAgents 🤝 x402 We just gave AI research agents the ability to pay for data and services on their own. Bio Protocol agents now use Coinbase Developer Platform🛡️'s x402 + Embedded Wallets for instant USDC micropayments on Base. What this unlocks: • AI agents pay each other and human researchers for specialized analysis • Pay-per-query instead of subscriptions • On-demand access to premium datasets • Hypothesis review marketplaces Imagine: An AI discovers a promising drug target, automatically commissions validation experiments, pays for the data, and refines its hypothesis - all without human intervention. BioAgents + x402 = a new scientific economy where AI, researchers, and labs seamlessly exchange intelligence and labor. The convergence of biotech, AI and onchain tech is here.

65,442 次观看

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.

Introducing the BIOS API: Turn Your Agent Into a Research Scientist Built to: 🦞 Add biomedical workflows to your OpenClaw🦞 agent 🧠 Create research or health agents w/ on-demand scientific intelligence 🧪 Pay per query via x402 on Base Any agent or app can now tap into the BIOS AI Scientist, plugging BIOS into the broader agent economy. What is BIOS? BIOS is an AI Scientist designed to handle complex biomedical research by orchestrating specialized scientific subagents. Ranked #1 on the leading bioinformatics benchmark, BIOS is already being used by 1,000+ researchers and labs to build new drugs and medicines. An Agentic Economy for Science AI agents have proven they can form multi-billion dollar ecosystems. BIOS applies the same primitives to drug discovery pipelines and health. Instead of coding bots and personal AI assistants, think research agent swarms running on a modern scientific stack. Imagine an OpenClaw agent built for longevity: It scans new literature daily, generates novel compound hypotheses through BIOS, designs validation workflows, and routes the best candidates to wet-lab funding - all programmatically. Connect it with an agent for microbiome health, enabling agent “backrooms” that autonomously surface cross-disciplinary insights. Micropayments for Scientific Work via x402 Each query triggers payment routing to BIOS and whichever subagents contribute to a response. The best agents earn. Usage settles instantly across contributing sources. The goal is pay-per-task science: paying for a CRISPR assay result, licensing a genomic dataset, or triggering a clinical data query - all settled in seconds via USDC. No purchase orders. No grant bureaucracy. No middlemen. x402 is the payment rail that makes agent-to-lab commerce possible - letting capital and cognition route themselves to the highest-signal science. What Will You Build? Drug discovery copilots? Longevity scouts? Automated literature monitors? Scientific due diligence agents? We’ll soon share the first implementations of the BIOS API. Stay tuned and see below for instructions on generating an API key for your agent or use-case.

25,659 次观看

New Gov Proposal: Use $RSC from the Bio treasury to fund ResearchHub study on Psilocybin’s Neuroprotective Role in Stroke • Scientific Focus: Psilocybin’s modulation of neuroprotective pathways in stroke-affected human brain tissue. • Strategic Impact: Enhance dealflow quality through trusted ResearchHub sourcing, enabling future IP sourcing, co-funding and shared R&D. 🔬 Read & vote: Voting ends 28 August at 8:16 PM CET.

New Gov Proposal: Use $RSC from the Bio treasury to fund ResearchHub study on Psilocybin’s Neuroprotective Role in Stroke • Scientific Focus: Psilocybin’s modulation of neuroprotective pathways in stroke-affected human brain tissue. • Strategic Impact: Enhance dealflow quality through trusted ResearchHub sourcing, enabling future IP sourcing, co-funding and shared R&D. 🔬 Read & vote: Voting ends 28 August at 8:16 PM CET.

54,597 次观看

S2 is near. This is the szn DeSci goes global. Details below.

S2 is near. This is the szn DeSci goes global. Details below.

33,953 次观看

Staking for $BIO and BioDAO tokens is now live on Ethereum Mainnet. → Staking gives you BioXP → BioXP = access to Ignition Sales 25M+ BIO has been staked since staking went live on Base a few days ago 🎉 DeSci swarms are cooking.

Staking for $BIO and BioDAO tokens is now live on Ethereum Mainnet. → Staking gives you BioXP → BioXP = access to Ignition Sales 25M+ BIO has been staked since staking went live on Base a few days ago 🎉 DeSci swarms are cooking.

39,435 次观看

tomorrow, seoul goes synthetic bio/acc rave KBW2026 20:00-3:30 roi perez (de) | christian smith (se) | closet yi (kr) | seoul's underground selectors $BIO holders get priority access 🧬 lineup + rsvp below:

tomorrow, seoul goes synthetic bio/acc rave KBW2026 20:00-3:30 roi perez (de) | christian smith (se) | closet yi (kr) | seoul's underground selectors $BIO holders get priority access 🧬 lineup + rsvp below:

27,991 次观看

🔗 Try BIOS here: 🔗 arXiv.org paper, "Rethinking the AI Scientist": 🔗 Learn more about the vision for BIOS and the Bio ecosystem:

🔗 Try BIOS here: 🔗 arXiv.org paper, "Rethinking the AI Scientist": 🔗 Learn more about the vision for BIOS and the Bio ecosystem:

15,448 次观看

Vitalik showed off his sample of 's first longevity product VD001 - a natural high dose spermidine supplement approved by the Thai FDA.

Vitalik showed off his sample of 's first longevity product VD001 - a natural high dose spermidine supplement approved by the Thai FDA.

34,179 次观看

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

10,537 次观看

We're still at the embryonic stage of autonomous science It's about to get so much cooler

We're still at the embryonic stage of autonomous science It's about to get so much cooler

17,724 次观看

The smallest bonds shape the largest futures

The smallest bonds shape the largest futures

17,753 次观看

Scientific progress does not fail because knowledge is absent. It slows in the interval between knowledge and application. The impediments lie less in discovery than in the structures that mediate it: governance, coordination, and the organizational inertia of collective work. The BioAgent Fleet is designed to intervene at this level. Each agent processes the overwhelming flow of scientific literature, inscribes structured insights into a decentralized knowledge graph, evaluates claims against benchmarks, and initiates experimental tasks in cloud-based laboratories. Considered separately, these agents appear as small units of computation. Considered together, they form an emergent architecture of cognition, accelerating the translation from data to hypothesis to validation. Their function is infrastructural, almost invisible, yet decisive. Without them, discoveries remain fragmented and inert. With them, knowledge acquires the velocity required to cross the gap between potential and realization. The next transformation in science will not be marked solely by singular breakthroughs. It will emerge from a new capacity to coordinate distributed intelligences into a coherent, accelerating system.

Scientific progress does not fail because knowledge is absent. It slows in the interval between knowledge and application. The impediments lie less in discovery than in the structures that mediate it: governance, coordination, and the organizational inertia of collective work. The BioAgent Fleet is designed to intervene at this level. Each agent processes the overwhelming flow of scientific literature, inscribes structured insights into a decentralized knowledge graph, evaluates claims against benchmarks, and initiates experimental tasks in cloud-based laboratories. Considered separately, these agents appear as small units of computation. Considered together, they form an emergent architecture of cognition, accelerating the translation from data to hypothesis to validation. Their function is infrastructural, almost invisible, yet decisive. Without them, discoveries remain fragmented and inert. With them, knowledge acquires the velocity required to cross the gap between potential and realization. The next transformation in science will not be marked solely by singular breakthroughs. It will emerge from a new capacity to coordinate distributed intelligences into a coherent, accelerating system.

14,755 次观看

Videos